関連する実験動画

Updated: Jul 4, 2025

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
05:51

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain

Published on: July 24, 2016

19.5K

妊娠中のCOVID-19ワクチン接種後の新生児の結果

Mikael Norman1,2, Maria C Magnus3, Jonas Söderling4

  • 1Department of Clinical Science, Intervention, and Technology, Karolinska Institutet, Stockholm, Sweden.

JAMA
|February 6, 2024
PubMed
まとめ

妊娠中にmRNAワクチンを用いたCOVID-19ワクチン接種は,新生児の有害事象を増加させなかった. この大規模な研究では,頭蓋内出血,低酸素発血性脳症,および予防接種を受けた乳児の死亡率が低いことが判明しました.

さらに関連する動画

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

86.0K
A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

6.4K

関連する概念動画

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
Vaccinations01:51

Vaccinations

Overview
44.5K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
309